New ASCO guidance narrows when PARP inhibitors should be used in ovarian cancer
An ASCO living guideline published Oct. 27, 2026, in the Journal of Clinical Oncology says everyone with newly diagnosed advanced ovarian cancer should get genetic testing, and that PARP inhibitor maintenance should…